11607 related articles for article (PubMed ID: 12119461)
21. Hereditary melanoma: Update on syndromes and management: Genetics of familial atypical multiple mole melanoma syndrome.
Soura E; Eliades PJ; Shannon K; Stratigos AJ; Tsao H
J Am Acad Dermatol; 2016 Mar; 74(3):395-407; quiz 408-10. PubMed ID: 26892650
[TBL] [Abstract][Full Text] [Related]
22. Heritable Gastrointestinal Cancer Syndromes.
Stoffel EM
Gastroenterol Clin North Am; 2016 Sep; 45(3):509-27. PubMed ID: 27546846
[TBL] [Abstract][Full Text] [Related]
23. Trichoepithelioma.
Johnson H; Robles M; Kamino H; Walters RF; Lee A; Sanchez M
Dermatol Online J; 2008 Oct; 14(10):5. PubMed ID: 19061604
[TBL] [Abstract][Full Text] [Related]
24. FRAMe: Familial Risk Assessment of Melanoma-a risk prediction tool to guide CDKN2A germline mutation testing in Australian familial melanoma.
Holland EA; Lo S; Kelly B; Schmid H; Cust AE; Palmer JM; Drummond M; Hayward NK; Pritchard AL; Mann GJ
Fam Cancer; 2021 Jul; 20(3):231-239. PubMed ID: 32989607
[TBL] [Abstract][Full Text] [Related]
25. [Familial pancreatic cancer--concept for study of the National Case Collection and early diagnosis program for high risk people].
Gerdes B; Kress R; Rieder H; Sina-Frey M; Przypadlo E; Barth P; Rehder H; Hahn SA; Schmiegel W; Rothmund M; Ziegler A; Bartsch DK
Z Arztl Fortbild Qualitatssich; 2002 May; 96(4):251-5. PubMed ID: 12068743
[TBL] [Abstract][Full Text] [Related]
26. Familial Pancreatic Cancer and the Future of Directed Screening.
Welinsky S; Lucas AL
Gut Liver; 2017 Nov; 11(6):761-770. PubMed ID: 28609837
[TBL] [Abstract][Full Text] [Related]
27. Familial pancreatic cancer.
Klein AP; Hruban RH; Brune KA; Petersen GM; Goggins M
Cancer J; 2001; 7(4):266-73. PubMed ID: 11561603
[TBL] [Abstract][Full Text] [Related]
28. [Hereditary gastric and pancreatic cancer predisposition syndromes].
Leoz ML; Sánchez A; Carballal S; Ruano L; Ocaña T; Pellisé M; Castells A; Balaguer F; Moreira L
Gastroenterol Hepatol; 2016; 39(7):481-93. PubMed ID: 26916701
[TBL] [Abstract][Full Text] [Related]
29. Risk of developing pancreatic cancer in families with familial atypical multiple mole melanoma associated with a specific 19 deletion of p16 (p16-Leiden).
Vasen HF; Gruis NA; Frants RR; van Der Velden PA; Hille ET; Bergman W
Int J Cancer; 2000 Sep; 87(6):809-11. PubMed ID: 10956390
[TBL] [Abstract][Full Text] [Related]
30. BRCA1 and pancreatic cancer: pedigree findings and their causal relationships.
Lynch HT; Deters CA; Snyder CL; Lynch JF; Villeneuve P; Silberstein J; Martin H; Narod SA; Brand RE
Cancer Genet Cytogenet; 2005 Apr; 158(2):119-25. PubMed ID: 15796958
[TBL] [Abstract][Full Text] [Related]
31. Management of familial melanoma and nonmelanoma skin cancer syndromes.
Santillan AA; Cherpelis BS; Glass LF; Sondak VK
Surg Oncol Clin N Am; 2009 Jan; 18(1):73-98, viii. PubMed ID: 19056043
[TBL] [Abstract][Full Text] [Related]
32. Molecular landscape of Hereditary Melanoma.
Ribeiro Moura Brasil Arnaut J; Dos Santos Guimarães I; Evangelista Dos Santos AC; de Moraes Lino da Silva F; Machado JR; de Melo AC
Crit Rev Oncol Hematol; 2021 Aug; 164():103425. PubMed ID: 34245855
[TBL] [Abstract][Full Text] [Related]
33. Intraductal papillary mucinous neoplasm of the pancreas: associated cancers, family history, genetic predisposition?
Lubezky N; Ben-Haim M; Lahat G; Marmor S; Solar I; Brazowski E; Nackache R; Klausner JM
Surgery; 2012 Jan; 151(1):70-5. PubMed ID: 21975290
[TBL] [Abstract][Full Text] [Related]
34. High Prevalence of Hereditary Cancer Syndromes and Outcomes in Adults with Early-Onset Pancreatic Cancer.
Bannon SA; Montiel MF; Goldstein JB; Dong W; Mork ME; Borras E; Hasanov M; Varadhachary GR; Maitra A; Katz MH; Feng L; Futreal A; Fogelman DR; Vilar E; McAllister F
Cancer Prev Res (Phila); 2018 Nov; 11(11):679-686. PubMed ID: 30274973
[No Abstract] [Full Text] [Related]
35. Association of family history of specific cancers with a younger age of onset of pancreatic adenocarcinoma.
McWilliams RR; Bamlet WR; Rabe KG; Olson JE; de Andrade M; Petersen GM
Clin Gastroenterol Hepatol; 2006 Sep; 4(9):1143-7. PubMed ID: 16861052
[TBL] [Abstract][Full Text] [Related]
36. Familial pancreatic cancer syndromes.
Habbe N; Langer P; Sina-Frey M; Bartsch DK
Endocrinol Metab Clin North Am; 2006 Jun; 35(2):417-30, xi. PubMed ID: 16632103
[TBL] [Abstract][Full Text] [Related]
37. Cancer risks and survival in patients with multiple primary melanomas: Association with family history of melanoma and germline CDKN2A mutation status.
Helgadottir H; Tuominen R; Olsson H; Hansson J; Höiom V
J Am Acad Dermatol; 2017 Nov; 77(5):893-901. PubMed ID: 28818438
[TBL] [Abstract][Full Text] [Related]
38. Increased risk of pancreatic cancer in melanoma-prone kindreds with p16INK4 mutations.
Goldstein AM; Fraser MC; Struewing JP; Hussussian CJ; Ranade K; Zametkin DP; Fontaine LS; Organic SM; Dracopoli NC; Clark WH
N Engl J Med; 1995 Oct; 333(15):970-4. PubMed ID: 7666916
[TBL] [Abstract][Full Text] [Related]
39. Cancer family history characterization in an unselected cohort of 121 patients with uveal melanoma.
Abdel-Rahman MH; Pilarski R; Ezzat S; Sexton J; Davidorf FH
Fam Cancer; 2010 Sep; 9(3):431-8. PubMed ID: 20157784
[TBL] [Abstract][Full Text] [Related]
40. Familial intraductal papillary mucinous neoplasms of the pancreas.
Rebours V; Couvelard A; Peyroux JL; Sauvanet A; Hammel P; Ruszniewski P; Lévy P
Dig Liver Dis; 2012 May; 44(5):442-6. PubMed ID: 21824831
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
